Atlas Venture Life Science Advisors, LLC Spero Therapeutics, Inc. Transaction History
Atlas Venture Life Science Advisors, LLC
- $810 Million
- Q3 2024
A detailed history of Atlas Venture Life Science Advisors, LLC transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Atlas Venture Life Science Advisors, LLC holds 402,885 shares of SPRO stock, worth $414,971. This represents 0.07% of its overall portfolio holdings.
Number of Shares
402,885
Previous 535,336
24.74%
Holding current value
$414,971
Previous $695,000
22.45%
% of portfolio
0.07%
Previous 0.09%
Shares
5 transactions
Others Institutions Holding SPRO
# of Institutions
49Shares Held
13.9MCall Options Held
200Put Options Held
200-
Anson Funds Management LP Dallas, TX3.75MShares$3.86 Million0.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.76MShares$1.82 Million0.0% of portfolio
-
Atlas Venture Associates Ix, LLC Boston, MA1.35MShares$1.39 Million14.54% of portfolio
-
Acadian Asset Management LLC Boston, MA1.07MShares$1.1 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny975KShares$1 Million0.0% of portfolio
About Spero Therapeutics, Inc.
- Ticker SPRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,067,500
- Market Cap $36.1M
- Description
- Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...